Kestra Advisory Services’s Clover Health Investments CLOV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$25K Sell
14,219
-111
-0.8% -$241 ﹤0.01% 3087
2025
Q4
$33.7K Sell
14,330
-1,399
-9% -$3.82K ﹤0.01% 4217
2025
Q3
$48.1K Buy
15,729
+3,246
+26% +$9.27K ﹤0.01% 2861
2025
Q2
$34.8K Buy
12,483
+883
+8% +$2.9K ﹤0.01% 2786
2025
Q1
$41.6K Sell
11,600
-343
-3% -$1.38K ﹤0.01% 2656
2024
Q4
$37.6K Buy
+11,943
New +$42.7K ﹤0.01% 2621

Other funds holding CLOV

Kestra Advisory Services's CLOV Position: Q1 2026 in Review

Kestra Advisory Services reduced its Clover Health Investments (CLOV) stake by 0.77% in Q1 2026, selling an estimated $241 and leaving 14,219 shares worth $25K. The position accounts for ﹤0.01% of the portfolio, ranked #3087.

Kestra Advisory Services first reported a position in CLOV in Q4 2024 and has held it in 6 quarters since. The position peaked at $48.1K in Q3 2025. 208 funds tracked by Wall St. Rank hold CLOV as of Q1 2026.

  • Kestra Advisory Services held 14,219 shares of Clover Health Investments worth $25K as of Q1 2026.
  • Kestra Advisory Services sold 111 Clover Health Investments shares in Q1 2026, an estimated $241.
  • Clover Health Investments made up ﹤0.01% of Kestra Advisory Services's portfolio in Q1 2026, its #3087 holding.
  • Kestra Advisory Services first reported a position in Clover Health Investments in Q4 2024 and has held it in 6 quarters since.
  • Kestra Advisory Services's Clover Health Investments position peaked at $48.1K in Q3 2025.
  • 208 funds tracked by Wall St. Rank held Clover Health Investments as of Q1 2026.

Based on Kestra Advisory Services's 13F filing for Q1 2026, filed 30 Apr 2026.